<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alcala K</submitter><funding>Umeå Universitet</funding><funding>World Cancer Research Fund</funding><funding>Cancer Research UK</funding><funding>Bengt Ihres Foundation</funding><funding>Svenska Läkaresällskapet</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>National Institute for Health and Care Research</funding><funding>Svensk-Franska Stiftelsen</funding><funding>NIHR Bristol Biomedical Research Centre</funding><pagination>e1004906</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12919923</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Excess body adiposity is an established cause of renal cancer, but underlying molecular pathways mediating this relationship remain unclear. This study aimed to systematically evaluate a panel of obesity-related risk factors as potential mediators in renal cancer etiology.&lt;h4>Methods and findings&lt;/h4>We used two complementary approaches to evaluate obesity-related risk factors in renal cancer etiology: (i) direct risk factor assessment in longitudinal cohorts and (ii) genetically proxied risk factors through two-sample mendelian randomization (MR). Direct risk-factor association-analyses (i.e., cohort analyses) were based on the UK Biobank cohort study (472,337 cohort participants, including 1,382 incident renal cancer cases diagnosed during 5,586,414 person years of fol</pubmed_abstract><journal>PLoS medicine</journal><pubmed_title>Systematic assessment of obesity-related risk factors in renal cancer etiology: A longitudinal risk and mendelian randomization analysis.</pubmed_title><pmcid>PMC12919923</pmcid><funding_grant_id>F0025_230413</funding_grant_id><funding_grant_id>NIHR202411</funding_grant_id><funding_grant_id>IIG_2019_1995</funding_grant_id><funding_grant_id>FS 2.1.6-59-23</funding_grant_id><funding_grant_id>C18281/A29019</funding_grant_id><funding_grant_id>MC_UU_00032/1</funding_grant_id><funding_grant_id>SLS-960379</funding_grant_id><funding_grant_id>BRC-1215-20011</funding_grant_id><funding_grant_id>PRCPGM-May25/100001</funding_grant_id><pubmed_authors>Brennan P</pubmed_authors><pubmed_authors>Franklin O</pubmed_authors><pubmed_authors>Pollak M</pubmed_authors><pubmed_authors>Alcala K</pubmed_authors><pubmed_authors>Langdon R</pubmed_authors><pubmed_authors>Jacobson S</pubmed_authors><pubmed_authors>Smith GD</pubmed_authors><pubmed_authors>Dimou N</pubmed_authors><pubmed_authors>Mariosa D</pubmed_authors><pubmed_authors>Martin RM</pubmed_authors><pubmed_authors>Johansson M</pubmed_authors><pubmed_authors>Gunter MJ</pubmed_authors><pubmed_authors>Coscia-Requena C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Systematic assessment of obesity-related risk factors in renal cancer etiology: A longitudinal risk and mendelian randomization analysis.</name><description>&lt;h4>Background&lt;/h4>Excess body adiposity is an established cause of renal cancer, but underlying molecular pathways mediating this relationship remain unclear. This study aimed to systematically evaluate a panel of obesity-related risk factors as potential mediators in renal cancer etiology.&lt;h4>Methods and findings&lt;/h4>We used two complementary approaches to evaluate obesity-related risk factors in renal cancer etiology: (i) direct risk factor assessment in longitudinal cohorts and (ii) genetically proxied risk factors through two-sample mendelian randomization (MR). Direct risk-factor association-analyses (i.e., cohort analyses) were based on the UK Biobank cohort study (472,337 cohort participants, including 1,382 incident renal cancer cases diagnosed during 5,586,414 person years of fol</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T10:01:36.958Z</modification><creation>2026-07-09T10:48:07.929Z</creation></dates><accession>S-EPMC12919923</accession><cross_references><pubmed>41666231</pubmed><doi>10.1371/journal.pmed.1004906</doi></cross_references></HashMap>